LEXICON PHARMACEUTICALS INC
NASDAQ: LXRX (Lexicon Pharmaceuticals, Inc.)
Last update: 56 minutes ago2.02
-0.13 (-6.05%)
| Previous Close | 2.15 |
| Volume | 2,937,951 |
| Price / Sales | 21.04 |
| Price / Book | 5.69 |
| 52 Weeks Range |
| Operating Margin (TTM) | -2,034.79% |
| Diluted EPS (TTM) | -0.500 |
| Quarterly Revenue Growth (YOY) | 11.70% |
| Total Debt/Equity (MRQ) | 86.37% |
| Current Ratio (MRQ) | 2.22 |
| Operating Cash Flow (TTM) | -167.43 M |
| Levered Free Cash Flow (TTM) | -93.95 M |
| Return on Assets (TTM) | -28.88% |
| Return on Equity (TTM) | -86.09% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Lexicon Pharmaceuticals, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -1.5 |
| Technical Oscillators | -0.5 |
| Average | -1.33 |
|
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 1.17% |
| % Held by Institutions | 74.93% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Artal Group S.A. | 30 Jun 2026 | 175,156,062 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |